Breaking News

New Research From Rabin Medical Center May Lead to Cure for Melanoma

March 10, 2017
A group of researchers from Tel Aviv University has discovered how malignant tumors from melanoma, the deadly skin cancer, work. The group is led by a young lecturer and researcher, Dr. Carmit Levy.


read more »

Rabin Medical Center Saves Breast Cancer Patients with New Mammography Techniques

March 3, 2017
A researcher at Zebra Medical Vision has created a new mammography algorithm that uses machine and deep learning to diagnose breast cancer (BC), with results that the company claims are superior to those achieved using current methods.


read more »

Medical School Graduates Rate Israel's Rabin Medical Center a Top Choice for Residency

February 24, 2017
The city that never stops – Tel Aviv – continues to be the strongest draw among medical school graduates who want to serve as interns in hospitals.


read more »

Fresh from the Blog: Vital Signs Health Trends

Weight Linked to Prostate Cancer Diagnosis

Prostate cancer is one of the most common types of cancer among men over the age of 60 in the U.S. According to David Levy, M.D., of Cleveland Clinic, “for the last couple of decades, one of the prevailing correlations has been weight and it seems over a number of different studies that have been… Continue reading Weight Linked to Prostate Cancer Diagnosis


read more »

New Gene Linked to Greater Risk of Brain & Ovarian Cancers

New Gene Linked to Greater Risk of Brain & Ovarian Cancers  Genetic changes and variants linked to the development of brain and ovarian cancers have been discovered in two new studies. This significant development offers researchers the chance to understand more about how these cancers develop and how they may one day be treated or… Continue reading New Gene Linked to Greater Risk of Brain & Ovarian Cancers


read more »

FDA Approves New Drug For Advanced Breast Cancer

U.S. regulators have approved a new drug called Kisqali as an initial treatment for postmenopausal women with a type of advanced breast cancer . The U.S. Food and Drug Administration confirmed the approval on March 13. Novartis said it will offer patients several types of financial assistance and many won’t have to make co-payments. Kisqali, developed by Novartis AG, is a… Continue reading FDA Approves New Drug For Advanced Breast Cancer


read more »